Balance Sheet

Assets

+64%

+162%

10Y

Currency: VND

	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	12 113	14 087	21 833	20 127	22 973	21 165	42 202	38 660	19 687	46 771	74 620	45 843	54 742	60 494	59 669	93 132	301 790	90 270
Cash	12 113	14 087	21 833	20 127	22 973	21 165	42 202	38 660	19 687	39 771	74 620	45 843	54 742	60 494	46 669	93 132	261 790	70 270
Cash Equivalents	0	0	0	0	0	0	0	0	0	7 000	0	0	0	0	13 000	0	40 000	20 000
Short-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	350 000	53 000	80 000	90 000
Total Receivables	40 505	42 809	54 977	64 645	66 098	86 887	62 308	77 360	100 020	82 540	94 430	114 416	199 411	276 462	162 856	155 385	112 375	157 276
Accounts Receivables	38 918	41 867	54 377	62 755	61 605	69 707	61 269	67 925	90 061	77 193	86 943	87 095	186 489	249 858	121 112	109 915	87 350	124 096
Other Receivables	1 587	942	600	1 890	4 493	17 180	1 039	9 435	9 959	5 347	7 487	27 321	12 922	26 604	41 744	45 470	25 025	33 180
Inventory	136 197	127 895	112 739	126 773	144 329	130 211	138 655	157 010	219 727	323 650	401 584	406 821	383 880	396 434	434 762	709 420	514 507	587 315
Other Current Assets	10 085	8 155	12 928	6 359	19 853	7 459	11 040	23 515	33 397	0	0	0	0	0	0	0	0	0
Total Current Assets	198 900	192 946	202 477	217 904	253 254	245 722	254 206	296 546	372 831	452 961	570 634	567 079	638 033	733 390	1 007 287	1 010 937	1 008 673	924 861
PP&E Net	39 914	39 635	40 286	45 960	48 749	45 204	58 895	57 102	55 950	52 606	56 442	63 814	90 068	166 103	212 752	442 074	791 736	976 101
PP&E Gross	39 914	39 635	40 286	45 960	48 749	45 204	58 895	57 102	55 950	52 606	56 442	63 814	90 068	166 103	212 752	442 074	791 736	976 101
Accumulated Depreciation	62 535	75 437	89 184	98 616	109 889	119 954	139 995	149 649	159 326	170 143	184 247	193 523	201 008	193 014	201 922	218 302	232 413	252 454
Intangible Assets	0	0	0	0	0	0	2 000	0	0	0	0	0	1 377	2 027	1 810	1 593	1 377	1 377
Note Receivable	0	0	0	0	0	0	0	10	10	10	10	0	0	0	0	0	0	0
Long-Term Investments	968	2 000	2 000	2 000	2 000	2 000	5 661	4 796	5 036	5 470	5 349	5 604	5 585	8 002	9 486	11 144	33 969	19 336
Other Long-Term Assets	0	0	0	0	90	105	4 017	1 610	2 738	2 920	2 274	2 627	3 157	10 525	6 256	3 754	2 510	4 631
Total Assets	239 782 N/A	234 581 -2%	244 763 +4%	265 864 +9%	304 093 +14%	293 031 -4%	324 780 +11%	360 063 +11%	436 565 +21%	513 967 +18%	634 709 +23%	639 124 +1%	738 220 +16%	920 046 +25%	1 237 591 +35%	1 469 502 +19%	1 838 264 +25%	1 926 305 +5%
Liabilities
Accounts Payable	26 179	28 384	23 006	31 156	19 994	28 715	38 450	36 979	63 065	64 431	73 887	92 807	168 134	260 362	113 994	196 455	146 324	235 207
Accrued Liabilities	1 246	1 509	3 196	2 739	4 241	1 707	4 250	4 936	6 832	8 664	8 741	15 435	15 676	12 668	14 674	16 251	11 573	20 104
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	195 122	161 942	204 182	289 429	234 630	333 483	373 274
Current Portion of Long-Term Debt	89 886	97 242	113 464	117 574	145 694	112 925	102 095	102 095	155 859	168 587	227 452	0	0	0	0	0	0	0
Other Current Liabilities	17 989	14 158	11 596	8 624	12 778	16 107	10 830	30 912	38 041	66 543	66 476	55 308	75 407	88 249	60 982	115 806	104 609	139 168
Total Current Liabilities	135 300	141 294	151 262	160 094	182 707	159 454	155 624	202 790	263 797	308 225	376 556	358 673	421 159	565 460	479 079	563 143	595 988	767 752
Long-Term Debt	20 035	9 991	5 860	4 260	1 613	1 061	1 255	210	210	210	210	210	210	0	0	102 213	170 218	96 913
Minority Interest	0	0	0	0	0	0	25 706	24 148	26 387	26 054	26 209	26 152	23 412	23 386	23 580	25 499	28 877	27 214
Other Liabilities	0	300	300	300	300	0	0	1 620	2 407	3 184	3 753	4 242	4 705	4 973	5 167	5 306	4 908	4 880
Total Liabilities	155 335 N/A	151 585 -2%	157 422 +4%	164 654 +5%	184 619 +12%	160 514 -13%	182 584 +14%	228 768 +25%	292 801 +28%	337 673 +15%	406 728 +20%	389 276 -4%	449 486 +15%	593 819 +32%	507 825 -14%	696 161 +37%	799 992 +15%	896 759 +12%
Equity
Common Stock	37 478	41 226	41 226	41 226	62 826	62 826	62 826	62 826	62 826	62 826	125 637	188 448	211 274	211 274	264 088	264 088	823 418	823 418
Retained Earnings	11 183	2 001	6 128	15 418	4 231	14 716	23 385	16 643	27 139	46 745	63 217	47 356	48 883	71 385	68 298	71 082	88 257	79 531
Additional Paid In Capital	26 849	26 849	26 849	26 849	29 335	29 335	29 335	29 335	29 335	29 335	1 000	1 000	1 000	1 000	315 934	315 934	97 320	97 320
Treasury Stock	0	0	0	0	15	15	15	8 270	9 427	9 427	8 697	8 084	8 084	8 084	8 084	8 084	8 084	8 084
Other Equity	8 937	12 920	13 138	17 717	23 096	25 654	26 664	30 761	33 891	46 815	46 825	21 128	35 661	50 652	89 528	130 321	37 362	37 362
Total Equity	84 447 N/A	82 996 -2%	87 341 +5%	101 210 +16%	119 474 +18%	132 517 +11%	142 196 +7%	131 295 -8%	143 765 +9%	176 294 +23%	227 981 +29%	249 848 +10%	288 734 +16%	326 227 +13%	729 766 +124%	773 341 +6%	1 038 273 +34%	1 029 546 -1%
Total Liabilities & Equity	239 782 N/A	234 581 -2%	244 763 +4%	265 864 +9%	304 093 +14%	293 031 -4%	324 780 +11%	360 063 +11%	436 565 +21%	513 967 +18%	634 709 +23%	639 124 +1%	738 220 +16%	920 046 +25%	1 237 591 +35%	1 469 502 +19%	1 838 264 +25%	1 926 305 +5%
Shares Outstanding
Common Shares Outstanding	17	19	19	19	21	21	21	21	21	21	21	21	21	59	74	81	91	91

Income Statement Balance Sheet Cash Flow Statement

HaTay Pharmaceutical JSC
VN:DHT

Balance Sheet

Balance Sheet Decomposition
HaTay Pharmaceutical JSC

Balance Sheet
HaTay Pharmaceutical JSC

See Also

Company

Help

Tools

Stocks

HaTay Pharmaceutical JSC VN:DHT

Balance Sheet

Balance Sheet Decomposition HaTay Pharmaceutical JSC

Balance Sheet HaTay Pharmaceutical JSC

See Also

Company

Help

Tools

Stocks

HaTay Pharmaceutical JSC
VN:DHT

Balance Sheet Decomposition
HaTay Pharmaceutical JSC

Balance Sheet
HaTay Pharmaceutical JSC